Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

1737 ARTÍCULOS , VIENDO DEL 1306 AL 1320

Risk of restless legs syndrome in low socioeconomic rheumatoid arthritis patients

Ishaq M, Sualeh Muhammad J, Hameed K.

Mod Rheumatol. 2013 Jul;23(4):705-8. doi: 10.1007/s10165-012-0714-x. Epub 2012 Jul 14.

Prospective study of restless legs syndrome and risk of depression in women

Li Y, Mirzaei F, O'Reilly EJ, Winkelman J, Malhotra A, Okereke OI, Ascherio A, Gao X.

Am J Epidemiol. 2012 Aug 15;176(4):279-88. doi: 10.1093/aje/kws016. Epub 2012 Jul 17.

ADMET considerations for restless leg syndrome drug treatments

de Biase S, Merlino G, Lorenzut S, Valente M, Gigli GL.

Expert Opin Drug Metab Toxicol. 2012 Oct;8(10):1247-61. doi: 10.1517/17425255.2012.708023. Epub 2012 Jul 18.

Dopa responsive burning mouth syndrome: restless mouth syndrome or oral variant of restless legs syndrome?

Prakash S, Ahuja S, Rathod C.

J Neurol Sci. 2012 Sep 15;320(1-2):156-60. doi: 10.1016/j.jns.2012.07.007. Epub 2012 Jul 21.

Capturing PLMS and their variability in children with sickle cell disease: does ankle activity monitoring measure up to polysomnography?

Rogers VE, Gallagher PR, Marcus CL, Ohene-Frempong K, Traylor JT, Mason TB.

Sleep Med. 2012 Sep;13(8):1013-20. doi: 10.1016/j.sleep.2012.06.016. Epub 2012 Jul 25.

Sleep-related eating disorder versus sleepwalking: a controlled study

Brion A, Flamand M, Oudiette D, Voillery D, Golmard JL, Arnulf I.

Sleep Med. 2012 Sep;13(8):1094-101. doi: 10.1016/j.sleep.2012.06.012. Epub 2012 Jul 25.

[Pharmacological and clinical profile of gabapentin enacarbil: a novel drug for the treatment of restless legs syndrome]

Kakimoto S, Ozawa T, Igarashi K, Tokuno T, Kaku S, Seki N.

Nihon Yakurigaku Zasshi. 2012 Aug;140(2):85-92. doi: 10.1254/fpj.140.85.

Relationship between sleep disorders and the risk for developing type 2 diabetes mellitus

Ioja S, Weir ID, Rennert NJ.

Postgrad Med. 2012 Jul;124(4):119-29. doi: 10.3810/pgm.2012.07.2573.

Prevalence of restless legs syndrome in a Georgian primary healthcare setting: a pilot study

Kuchukhidze G, Toidze I, Khatiashvili I, Maisuradze L, Frauscher B, Kasradze S, Högl B.

Eur Neurol. 2012;68(3):177-80. doi: 10.1159/000337938. Epub 2012 Aug 24.

Strategies for the treatment of restless legs syndrome

Buchfuhrer MJ.

Neurotherapeutics. 2012 Oct;9(4):776-90. doi: 10.1007/s13311-012-0139-4.

European guidelines on management of restless legs syndrome: report of a joint task force by the European Federation of Neurological Societies, the European Neurological Society and the European Sleep Research Society

Garcia-Borreguero D, Ferini-Strambi L, Kohnen R, O'Keeffe S, Trenkwalder C, Högl B, Benes H, Jennum P, Partinen M, Fer D, Montagna P, Bassetti CL, Iranzo A, Sonka K, Williams AM; European Federation of Neurological Societies; European Neurological Society; European Sleep Research Society.

Eur J Neurol. 2012 Nov;19(11):1385-96. doi: 10.1111/j.1468-1331.2012.03853.x. Epub 2012 Sep 3.

Assessing health-related quality of life in patients with restless legs syndrome in Korea: comparison with other chronic medical diseases

Cho YW, Kim DH, Allen RP, Earley CJ.

Sleep Med. 2012 Oct;13(9):1158-63. doi: 10.1016/j.sleep.2012.05.005. Epub 2012 Aug 30.

Nocturnal leg cramps

Allen RE, Kirby KA.

Am Fam Physician. 2012 Aug 15;86(4):350-5.

Transdermal rotigotine for the perioperative management of restless legs syndrome

Högl B, Oertel WH, Schollmayer E, Bauer L.

BMC Neurol. 2012 Sep 25;12:106. doi: 10.1186/1471-2377-12-106.

Application of the Cambridge-Hopkins diagnostic questionnaire for investigating restless legs syndrome in patients with chronic renal failure

Gholamrezaei A, Saadatnia M.

Sleep Med. 2013 Feb;14(2):225. doi: 10.1016/j.sleep.2012.09.002. Epub 2012 Oct 1.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias